[Data],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lane,Sample_ID,Sample_Name,GenomeFolder,Index,bait_name,default_library_type,default_tag_sequence,default_tagtwo_sequence,email_addresses,email_addresses_of_followers,email_addresses_of_managers,email_addresses_of_owners,is_control,is_pool,lane_id,lane_priority,library_name,organism,organism_taxon_id,project_cost_code,project_id,project_name,qc_state,request_id,required_insert_size_range,sample_accession_number,sample_cohort,sample_common_name,sample_consent_withdrawn,sample_description,sample_donor_id,sample_id,sample_name,sample_public_name,sample_reference_genome,sample_supplier_name,spiked_phix_tag_index,study_accession_number,study_alignments_in_bam,study_contains_nonconsented_human,study_contains_nonconsented_xahuman,study_description,study_id,study_name,study_reference_genome,study_separate_y_chromosome_data,study_title,tag_index,
3,14848484,ERS812459,,ATCACG,,RNA-seq dUTP eukaryotic,ATCACG,,mg16@sanger.ac.uk ncb@sanger.ac.uk,,ncb@sanger.ac.uk,mg16@sanger.ac.uk,0,0,,,,,10090,S0815,1608,RNA sequencing of mouse haemopoietic cells,,,from:100 to:300,ERS812459,,Mus musculus,,Total RNA extracted from Lin_neg_bone marrow,,2377275,3291STDY6178377,DSMX47_4E,,,888,ERP006862,1,0,0,Comprehensive analysis of AML genomes has revealed co-occurring mutations in DNA and%0Ahistone modifying enzymes suggesting their crucial role in tumourigenesis. To gain inside into%0Athe role of those genes in AML we generated mouse models recapitulating mutations in part%0Aof the most frequent ones. We hypothesise that aberrant chromatin modification and%0Aunderlying effect on gene expression largely contribute to leukemogenesis. To test this%0Ahypothesis we propose to compare gene expression and DNA and histone modification in the%0Apresence or absence of single gene mutation in mouse hematopoietic stem and progenitor%0Acompartment in a pre-leukaemia setting. Characterisation of these models will inform the%0Abiology of AML%2C identify potential therapeutic targets and provide platforms for the%0Aassessment of novel therapeutics.%0A%0A%0AThis data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,3291,RNA sequencing of mouse haemopoietic cells 2014%2F15,Mus_musculus (GRCm38 + ensembl_75_transcriptome) [star],,RNA sequencing of mouse haemopoietic cells 2014%2F15,1,
3,14848496,ERS812460,,CGATGT,,RNA-seq dUTP eukaryotic,CGATGT,,mg16@sanger.ac.uk ncb@sanger.ac.uk,,ncb@sanger.ac.uk,mg16@sanger.ac.uk,0,0,,,,,10090,S0815,1608,RNA sequencing of mouse haemopoietic cells,,,from:100 to:300,ERS812460,,Mus musculus,,Total RNA extracted from Lin_neg_bone marrow,,2377276,3291STDY6178378,DSMX47_4F,,,888,ERP006862,1,0,0,Comprehensive analysis of AML genomes has revealed co-occurring mutations in DNA and%0Ahistone modifying enzymes suggesting their crucial role in tumourigenesis. To gain inside into%0Athe role of those genes in AML we generated mouse models recapitulating mutations in part%0Aof the most frequent ones. We hypothesise that aberrant chromatin modification and%0Aunderlying effect on gene expression largely contribute to leukemogenesis. To test this%0Ahypothesis we propose to compare gene expression and DNA and histone modification in the%0Apresence or absence of single gene mutation in mouse hematopoietic stem and progenitor%0Acompartment in a pre-leukaemia setting. Characterisation of these models will inform the%0Abiology of AML%2C identify potential therapeutic targets and provide platforms for the%0Aassessment of novel therapeutics.%0A%0A%0AThis data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,3291,RNA sequencing of mouse haemopoietic cells 2014%2F15,Mus_musculus (GRCm38 + ensembl_75_transcriptome),,RNA sequencing of mouse haemopoietic cells 2014%2F15,2,
3,14848508,ERS812461,,TTAGGC,,RNA-seq dUTP eukaryotic,TTAGGC,,mg16@sanger.ac.uk ncb@sanger.ac.uk,,ncb@sanger.ac.uk,mg16@sanger.ac.uk,0,0,,,,,10090,S0815,1608,RNA sequencing of mouse haemopoietic cells,,,from:100 to:300,ERS812461,,Mus musculus,,Total RNA extracted from Lin_neg_bone marrow,,2377277,3291STDY6178379,DSMX47_4G,,,888,ERP006862,1,0,0,Comprehensive analysis of AML genomes has revealed co-occurring mutations in DNA and%0Ahistone modifying enzymes suggesting their crucial role in tumourigenesis. To gain inside into%0Athe role of those genes in AML we generated mouse models recapitulating mutations in part%0Aof the most frequent ones. We hypothesise that aberrant chromatin modification and%0Aunderlying effect on gene expression largely contribute to leukemogenesis. To test this%0Ahypothesis we propose to compare gene expression and DNA and histone modification in the%0Apresence or absence of single gene mutation in mouse hematopoietic stem and progenitor%0Acompartment in a pre-leukaemia setting. Characterisation of these models will inform the%0Abiology of AML%2C identify potential therapeutic targets and provide platforms for the%0Aassessment of novel therapeutics.%0A%0A%0AThis data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,3291,RNA sequencing of mouse haemopoietic cells 2014%2F15,Mus_musculus (GRCm38 + ensembl_75_transcriptome) [star],,RNA sequencing of mouse haemopoietic cells 2014%2F15,3,
3,12172503,phiX_for_spiked_buffers,,ACAACGCAATC,,,ACAACGCAATC,,hps@sanger.ac.uk,,hps@sanger.ac.uk,hps@sanger.ac.uk,1,0,,,PhiXBPS24Oct14,,10847,,,,,,,,,,,,,1255141,phiX_for_spiked_buffers,,,,888,,1,0,0,None,198,Illumina Controls,,,,888,
4,14848484,ERS812459,,ATCACG,,RNA-seq dUTP eukaryotic,ATCACG,,mg16@sanger.ac.uk ncb@sanger.ac.uk,,ncb@sanger.ac.uk,mg16@sanger.ac.uk,0,0,,,,,10090,S0815,1608,RNA sequencing of mouse haemopoietic cells,,,from:100 to:300,ERS812459,,Mus musculus,,Total RNA extracted from Lin_neg_bone marrow,,2377275,3291STDY6178377,DSMX47_4E,,,888,ERP006862,1,0,0,Comprehensive analysis of AML genomes has revealed co-occurring mutations in DNA and%0Ahistone modifying enzymes suggesting their crucial role in tumourigenesis. To gain inside into%0Athe role of those genes in AML we generated mouse models recapitulating mutations in part%0Aof the most frequent ones. We hypothesise that aberrant chromatin modification and%0Aunderlying effect on gene expression largely contribute to leukemogenesis. To test this%0Ahypothesis we propose to compare gene expression and DNA and histone modification in the%0Apresence or absence of single gene mutation in mouse hematopoietic stem and progenitor%0Acompartment in a pre-leukaemia setting. Characterisation of these models will inform the%0Abiology of AML%2C identify potential therapeutic targets and provide platforms for the%0Aassessment of novel therapeutics.%0A%0A%0AThis data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,3291,RNA sequencing of mouse haemopoietic cells 2014%2F15,Mus_musculus (GRCm38 + ensembl_84_transcriptome) [aligneroranalysisxyz],,RNA sequencing of mouse haemopoietic cells 2014%2F15,1,
4,14848496,ERS812460,,CGATGT,,RNA-seq dUTP eukaryotic,CGATGT,,mg16@sanger.ac.uk ncb@sanger.ac.uk,,ncb@sanger.ac.uk,mg16@sanger.ac.uk,0,0,,,,,10090,S0815,1608,RNA sequencing of mouse haemopoietic cells,,,from:100 to:300,ERS812460,,Mus musculus,,Total RNA extracted from Lin_neg_bone marrow,,2377276,3291STDY6178378,DSMX47_4F,,,888,ERP006862,1,0,0,Comprehensive analysis of AML genomes has revealed co-occurring mutations in DNA and%0Ahistone modifying enzymes suggesting their crucial role in tumourigenesis. To gain inside into%0Athe role of those genes in AML we generated mouse models recapitulating mutations in part%0Aof the most frequent ones. We hypothesise that aberrant chromatin modification and%0Aunderlying effect on gene expression largely contribute to leukemogenesis. To test this%0Ahypothesis we propose to compare gene expression and DNA and histone modification in the%0Apresence or absence of single gene mutation in mouse hematopoietic stem and progenitor%0Acompartment in a pre-leukaemia setting. Characterisation of these models will inform the%0Abiology of AML%2C identify potential therapeutic targets and provide platforms for the%0Aassessment of novel therapeutics.%0A%0A%0AThis data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,3291,RNA sequencing of mouse haemopoietic cells 2014%2F15,Mus_musculus (GRCm38 + ensembl_84_transcriptome) [star],,RNA sequencing of mouse haemopoietic cells 2014%2F15,2,
4,14848508,ERS812461,,TTAGGC,,RNA-seq dUTP eukaryotic,TTAGGC,,mg16@sanger.ac.uk ncb@sanger.ac.uk,,ncb@sanger.ac.uk,mg16@sanger.ac.uk,0,0,,,,,10090,S0815,1608,RNA sequencing of mouse haemopoietic cells,,,from:100 to:300,ERS812461,,Mus musculus,,Total RNA extracted from Lin_neg_bone marrow,,2377277,3291STDY6178379,DSMX47_4G,,,888,ERP006862,1,0,0,Comprehensive analysis of AML genomes has revealed co-occurring mutations in DNA and%0Ahistone modifying enzymes suggesting their crucial role in tumourigenesis. To gain inside into%0Athe role of those genes in AML we generated mouse models recapitulating mutations in part%0Aof the most frequent ones. We hypothesise that aberrant chromatin modification and%0Aunderlying effect on gene expression largely contribute to leukemogenesis. To test this%0Ahypothesis we propose to compare gene expression and DNA and histone modification in the%0Apresence or absence of single gene mutation in mouse hematopoietic stem and progenitor%0Acompartment in a pre-leukaemia setting. Characterisation of these models will inform the%0Abiology of AML%2C identify potential therapeutic targets and provide platforms for the%0Aassessment of novel therapeutics.%0A%0A%0AThis data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,3291,RNA sequencing of mouse haemopoietic cells 2014%2F15,Mus_musculus (GRCm38 + ensembl_84_transcriptome),,RNA sequencing of mouse haemopoietic cells 2014%2F15,3,
6,14801132,Kolf_22_1,,CGATGT,,RNA-seq dUTP,CGATGT,,deh@sanger.ac.uk,,deh@sanger.ac.uk,deh@sanger.ac.uk,0,0,,,Kolf_22_1 14801132,Homo sapiens,9606,S0979,1493,Pathogen host sequencing,,,from:100 to:1000,,,Homo sapiens,,,,2381772,Kolf_22_1,,,,888,,1,0,0,To generate an RNA-Seq dataset for organoids stimulated with IL-22%3B Salmonella Typhimurium%3B IL-22 and Salmonella Typhimurium%3B and unstimulated.%0AThese data are part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,3784,I2134 Transcriptional response of Kolf2 intestinal organoids to IL-22 (GD),Homo_sapiens (GRCh38_15),1,Transcriptional response of Kolf2 intestinal organoids to IL-22,2,
6,12172503,phiX_for_spiked_buffers,,ACAACGCAATC,,,ACAACGCAATC,,hps@sanger.ac.uk,,hps@sanger.ac.uk,hps@sanger.ac.uk,1,0,,,PhiXBPS24Oct14,,10847,,,,,,,,,,,,,1255141,phiX_for_spiked_buffers,,,,888,,1,0,0,None,198,Illumina Controls,,,,888,
8,14727840,ERS811018,,CGATGTTT,,ChIP-Seq Auto,CGATGTTT,,mg16@sanger.ac.uk ncb@sanger.ac.uk,,ncb@sanger.ac.uk,mg16@sanger.ac.uk,0,0,,,,,10090,S0815,1927,Analysis of the chromatin state of mouse stem and progenitor cell compartment S0815,,,from:100 to:1000,ERS811018,,Mus musculus,,Lin_neg_bone marrow,,2376982,2905STDY6178180,UTX_IP_UTX_GTX_A,,,888,ERP004563,1,0,0,This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F%0A,2905,Analysis of the chromatin state of mouse stem and progenitor cell compartment,Mus_musculus (GRCm38),,Analysis of the chromatin state of mouse stem and progenitor cell compartment,1,
8,14727876,ERS811021,,ACAGTGGT,,ChIP-Seq Auto,ACAGTGGT,,mg16@sanger.ac.uk ncb@sanger.ac.uk,,ncb@sanger.ac.uk,mg16@sanger.ac.uk,0,0,,,,,10090,S0815,1927,Analysis of the chromatin state of mouse stem and progenitor cell compartment S0815,,,from:100 to:1000,ERS811021,,Mus musculus,,Lin_neg_bone marrow,,2376985,2905STDY6178183,UTX_IP_UTX_Bethyl_C,,,888,ERP004563,1,0,0,This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F%0A,2905,Analysis of the chromatin state of mouse stem and progenitor cell compartment,Mus_musculus (GRCm38 + ensembl_84_transcriptome) [star],,Analysis of the chromatin state of mouse stem and progenitor cell compartment,2,
8,12172503,phiX_for_spiked_buffers,,ACAACGCAATC,,,ACAACGCAATC,,hps@sanger.ac.uk,,hps@sanger.ac.uk,hps@sanger.ac.uk,1,0,,,PhiXBPS24Oct14,,10847,,,,,,,,,,,,,1255141,phiX_for_spiked_buffers,,,,888,,1,0,0,None,198,Illumina Controls,,,,888,
